Lenvatinib Carbamoyl Derivative

SZ CAT No:	SZ-L038048
CAS No	NA
Mol.F.	C25H24ClN5O5
Mol.Wt.	509.9
Inv. Status	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Chemical Name: 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-N-(cyclopropylcarbamoyl)-7-methoxyquinoline-6-carboxamide

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Smiles: ClC1=CC(OC2=CC=NC3=CC(OC)=C(C(NC(NC4CC4)=O)=O)C=C32)=CC=C1NC(NC5CC5)=O

Stability indicating UPLC method development and validation of lenvatinib
By Sai, Prasanna A.; Kumar, Meruva Sathish; Kumari, R. V. Valli; Marakatham, S.
From International Journal of Pharmacy and Biological Sciences (2019), 9(3), 605-614

Method validation studies and an inter-laboratory cross validation study of lenvatinib assay in human plasma using LC-MS/MS
By Mano Yuji
From Practical laboratory medicine (2018), 12, e00103

Lenvatinib Carbamoyl Derivative is chemically 4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-N-(cyclopropylcarbamoyl)-7-methoxyquinoline-6-carboxamide. Lenvatinib Carbamoyl Derivative is supplied with detailed characterization data compliant with regulatory guideline. Lenvatinib Carbamoyl Derivative can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenvatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Lenvatinib Carbamoyl Derivative

Contacts

Our Locations